KLK3 and prostate carcinoma: Rapid worsening of performance status, low serum PSA despite high tumour burden, visceral metastases (particularly lung and liver) and osteolytic bone metastases, should lead physicians to suspect NE differentiation of prostate cancer either de novo or as CRPC [19].